schema:articleBody
| - JEOL Ltd. (TOKYO:6951) (President & COO Izumi Oi) has opened a new facility in JEOL (EUROPE) B.V. (Zaventem, Belgium) on October 1, 2020, aiming to strengthen the Medical Equipment business in Europe. This press release features multimedia. View the full release here: Demo site JEOL (EUROPE) B.V. (Photo: Business Wire) This foundation, with three instruments in operation, not only offers customers the possibility of practical demonstrations and intensive service / application training, but also enables high-quality service and fast logistics from the dedicated warehouse. This new approach is based on a long-term plan that whilst keeping pace with a high standard and matured medical environment in Europe, we will also cover emerging regions such as the Middle East, Eastern Europe and Russia, where the expected growth in economy and population can lead to a steady demand for medical infrastructure. We will continue to promote overseas business intensively and hope that this new operation will be a milestone for more customer-oriented sales and service activities. JEOL (EUROPE) B.V.: Products (Clinical Chemistry Analyzer ): JEOL Ltd. 3-1-2, Musashino, Akishima, Tokyo, 196-8558, Japan Izumi Oi, President & COO (Stock code: 6951, Tokyo Stock Exchange First Section) www.jeol.com View source version on businesswire.com: Contact Hideyuki TANABE E-mail: htanabe@jeol.co.jp JEOL (GERMANY) GmbH Gute Aenger 30, 85356 Freising, Germany Corporate URL: Contact Form: TEL: +49-8161-9845-0 FAX: +49-8161-9845-100 Taishi SAKAI E-mail: sakai@jeolbenelux.com JEOL (EUROPE) B.V. Planet II, Gebouw B, Leuvensesteenweg 542, B-1930 Zaventem, Belgium Corporate URL: Contact Form: TEL: +32-2-720-0560 FAX: +32-2-720-6134 © 2020 Business Wire, Inc. Disclaimer: This material is not an AFP editorial material, and AFP shall not bear responsibility for the accuracy of its content. In case you have any questions about the content, kindly refer to the contact person/entity mentioned in the text of the release.
|